Antiepileptic Drugs Market

Date: 2016-05

Antiepileptic drugs are used to treat patients with epilepsy. Epilepsy is a brain disorder, which leads to a patient having seizures whenever a set of neurons send proper electrical impulses. Epilepsy has a psychological effect on patients in that it affects their day-to-day activities making otherwise normal day chores a challenge. The cause for epilepsy has still yet not been determined althrough many believe that drastic lifestyle changes have led to the onset of epilepsy across the globe. Some of these lifestyle changes include smoking, alcohol abuse, drugs abuse etc. Antiepileptic drugs are able to arrest the symptoms of epilepsy to a certain extent. The degree to which the symptoms can be spressed depends on the age of the patient, the degree to which the individual has been affected and the general body constitution of the patient.

In terms of geographical contribution, the North American region accounts for the highest share of the antiepileptic drugs market. This is in part due to two main reasons, the first being that the condition of epilepsy was recognized in this region whereas in other regions such as APAC and Latin America, it was not recognized as a condition. Further to this, the level of research, which takes place for neurology is the highest in North America and as such, the reason was one of the first to bring in antiepileptic drugs. As on date, it is estimated that close to 3 million individuals in the United States alone have been recognized as having been affected by epilepsy. The United States was one of the first few countries, which was able to utilize the second-generation antiepileptic drugs.

Countries in Asia have now also recognized epilepsy and now possess a huge potential for the antiepileptic drug market. Countries like China, India and Thailand have a large number of cases of epilepsy that are now also being treated with antiepileptic drugs.

Antiepileptic Drugs Market

The Antiepileptic Drugs market can be segmented on the basis of type as
First Generation Drugs:
Valproate (Depakote)
Oxycarbazepine ((Trileptal)
Carbamazepine (Carbatrol)
Phenobarbital (Luminal)
Primidone (Mysoline)
Ethosuximide (Zarontin)
Topiramate (Topamax)
Second Generation Drugs:
Lamotrigine (Lamictal)
Pregabalin (Lyrica)
Eslicarbazepine acetate Zonisamide (Zonegran)
Lacosamide (Vimpat)
Levetiracetam (Keppra)
Perampanel (Fycompa)
Rufinamide (Banzel/Inovelon)
Ezogabine/retigabine (Trobalt/Potiga)
Pipeline Drugs:
UCB0942 (PPSI)
Brivaracetam (UCB Pharma Ltd)
Ganaxolone (Marinus Pharmaceuticals)
USL261 (Upsher Smith Laboratories, Inc.)
Perampanel (Eisai Co)
YKP3089 (SK Life Sciences)

The market has been segmented based on the following geographies:
North America
South America
Middle East

Following are just a few of the companies that are operating in the Antiepileptic Drugs market:
Abbott Laboratories
Johnson & Johnson
Novartis AG


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample